Inactive Instrument

News GlaxoSmithKline plc London S.E.

Stocks

Pharmaceuticals

End-of-day quote London S.E.
- ^GBX	-

02:53pm	GSK plc Presents at Bernstein?s 23rd Annual Pan-European Strategic Decisions Conference, Sep-09-2026 08:00 AM
01:56pm	The Fed's September Squeeze

All News

Mentions Relevance

02:53pm	GSK plc Presents at Bernstein?s 23rd Annual Pan-European Strategic Decisions Conference, Sep-09-2026 08:00 AM
01:35pm	RBC Capital Markets Initiates GSK at Sector Perform	MT
10:54am	GSK Initiated at Sector Perform as RBC Notes 'Limited' Margin for Error to Reach FY31 Revenue Target	MT
09-08	GSK plc : RBC revises his opinion and turns to Neutral	ZD
09-08	GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition	MT
09-08	GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition, Bloomberg Reports	MT
09-08	GSK Commences Six-Part Dollar Bond Sale to Help Fund Nuvalent Acquisition	MT
09-08	GSK Launches Six-Part Dollar Bond Sale to Support Nuvalent Acquisition Financing, Bloomberg Reports	MT
09-08	GSK plc : Barclays keeps a Sell rating	ZD
09-03	WINNERS & LOSERS: Hutchmed pens GSK deal; Gem Diamonds back in profit	AN
09-03	Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830	AN
09-03	Hutchmed Signs Cancer Treatment Licensing Agreement With GSK; Shares Rise Pre-Bell	MT
09-03	HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug	RE
09-03	Hutchmed Enters Licensing Agreement With GSK for Cancer Drug	DJ
09-03	Hutchmed Grants GSK Global Rights to KRAS-EGFR Antibody Conjugate Cancer Therapy	MT
09-03	HUTCHMED (China) signs exclusive licensing deal with GSK for investigational cancer drug	RE
09-02	GSK plc : Deutsche Bank reiterates its Neutral rating	ZD
09-01	Gsk Advances Mrna Flu Vaccine Candidate to Phase Iii Following Positive Phase Ii Data	CI
09-01	GSK advances mRNA flu vaccine to phase 3 after positive results	AN
09-01	GSK plc : JP Morgan gives a Sell rating	ZD
09-01	GSK Plans Phase 3 Trial for mRNA Flu Vaccine Candidate	MT
09-01	GSK Plans Late-stage Trial for Flu Vaccine After Positive Phase 2 Results	MT
09-01	GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial	DJ
09-01	GSK to advance mRNA flu vaccine to late-stage trial	RE
08-26	GSK's ViiV Healthcare Says US FDA Approves Tivicay PD for Pediatric HIV Patients	MT